novo nordisk ozempic - Search News

News

Hims, Novo Nordisk

Novo Nordisk Abruptly Ends Partnership with Hims, Claiming ‘Sham Compounding’ GLP-1 Drugs

The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent mandate. Hims pushed back against the accusation.

CBS News on MSN · 1d

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

Bloomberg on MSN · 7h

Novo exits Hims & Hers partnership, citing ‘deceptive marketing’ concerns

Novo Nordisk A/S scrapped a partnership with Hims & Hers Health Inc. after less than two months, saying the US company is using “deceptive marketing” to sell copycat versions of its obesity blockbuster Wegovy.

Novo Nordisk launches weight-loss drug Wegovy

Barron's on MSN · 1d

Novo Nordisk Stock Drops on Weight-Loss Data. Why Investors Have Doubts.

Novo Nordisk unveiled its latest data for a weight-loss drug candidate, but shares of the maker of Wegovy and Ozempic tumbled as the results missed investors’ expectations and reignited concerns about Novo’s rivalry with Eli Lilly.

Novo Nordisk preparing to launch weight-loss drug Wegovy in India

Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes that its position as a market leader for insulin products in the country could give it an edge.

CNBCTV18 · 14h

Novo Nordisk launches blockbuster weight loss drug Wegovy in India

Wegovy is only approved for obesity in India. Novo Nordisk has no immediate plans to launch Ozempic for type 2 diabetes, though it is exploring oral semaglutide for obesity.

1don MSN

EU drugs regulator to allow Novo Nordisk to include heart condition in Ozempic label

Novo Nordisk said on Monday the European drugs regulator will allow a label update for its diabetes drug Ozempic to include a ...

Ozempic maker announces not one, but three new weight-loss drugs

Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...

6h

Ozempic Might Be a Dementia Buster, Too

Research out today is the latest to suggest that semaglutide can significantly lower people's risk of dementia.

4don MSN

US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list

A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...

24/7 Wall St.4d

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (June 2025)

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Futurism on MSN5d

Something Comically Bad Just Happened to the Inventor of Ozempic

Novo Nordisk, the Danish pharma company behind Ozempic, made a very dumb decision a few years ago that will massively eat ...

3d

New ‘Ozempic pill’ is better than ‘skinny jabs’ and helps you lose weight even faster, study suggests

A NEW ‘Ozempic pill’ leads to faster weight loss than the popular ‘skinny jabs’, studies have suggested. The new weight loss ...

Could a Novo error set up early GLP-1 generics in Canada?

It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results